The city’s iconic London Landmarks Half Marathon gets set to take off April 3, 2024 London Landmarks Half Marathon will see 18,500 runners and wheelchair participants taking to the streets of the city for this iconic event.
Work-related stress and how to manage it effectively April 2, 2024 Dealing with stress in the workplace is a challenge that often comes with the territory of any high-pressure job.
ASMR is coming to the spa near to you April 2, 2024 ASMR is breaking through the screen and into the spa treatment room, says Kat Romero. Are you ready for a calming, whispering massage?
Holland & Barrett increase staff pay to a minimum of £12 an hour April 1, 2024 Holland & Barrett is set to increase its hourly pay for store colleagues by nine per cent, from £11 to £12, almost five per cent per cent above the new National Living Wage.
On the brink: Alcohol and high-achieving professional women March 27, 2024 Although the word 'alcoholic' may conjure a particular stereotypical image, professional middle-aged women in their 40s and 50s are becoming more prone to addiction.
Rock on: London Climbing Centres celebrates reaching 10-year milestone March 25, 2024 One million people take on the challenge of indoor climbing each year, with a dedicated 100,000 enthusiasts scaling the walls at least twice a month.
Living the high life: Upgrading the wellness travel experience March 24, 2024 Celebrating its 20th anniversary this month, VistaJet landed at Farnborough Airport with a Global 7500 to roll out its new Wellness programme.
AI-driven sepsis and infection tests rolled out to NHS with £1.5m funding March 21, 2024 A UK start-up has employed the power of artificial intelligence to help enhance the diagnosis of sepsis.
City’s top motivational wellness speakers, according to poll March 20, 2024 A new poll has revealed the most sought-after wellbeing experts who are being booked for events across the capital.
‘Anxiety drug’ pregabalin addiction surge sparks pleas for mental health support March 19, 2024 Pregabalin, sold under the brand names Lyrica, Alzain and Axalid, has been linked to nearly 3,400 deaths in Britain in the last five years.